Latest filing published 13 Aug 2009 for AVANIR PHARMACEUTICALS, €142k.
Insider track record
No signal scores available.
Vivo Ventures Fund VI, L.P.: trading record in brief
Vivo Ventures Fund VI, L.P. appears in our data through filings on Avanir Pharmaceuticals shares, published by SEC (Form 4). Over a trading history stretching from 28 July 2009 to 11 August 2009, the count stands at 6 filings.
Sales make up the whole of the open-market record (6 sales, €1.4M).
On 13 August 2009 came the latest disclosure, an open-market sale for €142k in Avanir Pharmaceuticals. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Vivo Ventures Fund VI, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 49,800 shares@ US$4.05Common StockSEC:0001019687-09-002866:0
- 232,450 shares@ US$3.3725Common StockSEC:0001019687-09-002866:1
- 122,100 shares@ US$2.4219Common StockSEC:0001019687-09-002694:0
- 145,500 shares@ US$2.2766Common StockSEC:0001019687-09-002694:1
- 142,366 shares@ US$2.293Common StockSEC:0001019687-09-002694:2
- 1,400 shares@ US$2.20Common StockSEC:0001019687-09-002694:3
6 of 6 declarations
